Preliminary results from a phase Ib study of neoadjuvant ipilimumab plus nivolumab prior to liver resection for hepatocellular carcinoma: The PRIME-HCC trial.
| Image |  |
|---|---|
| Description | scientific article published in 2022 |
| Author/s |
author: Alessio Cortellini |
| Publication date | June 1, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |